Hull York Medical School
Academic Diabetes Endocrinology and Metabolism
Obesity explains the reduced quality of life found in polycystic ovary syndrome
Glucagon like peptide-1 analogue, Liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and non-alcoholic fatty liver disease
SOMATOSTATIN RECEPTOR EXPRESSION IN THYROID DISEASE
The effect of atorvastatin on adipose tissue inflammation and dysfunction in women with polycystic ovary syndrome
Acute hypertriglyceridaemia induces platelet hyperactivity that is not attenuated by insulin in PCOS – a mechanism for enhanced cardiovascular risk?